These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24587765)

  • 1. Discovery of novel inhibitors for Nek6 protein through homology model assisted structure based virtual screening and molecular docking approaches.
    Srinivasan P; Chella Perumal P; Sudha A
    ScientificWorldJournal; 2014; 2014():967873. PubMed ID: 24587765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.
    De Donato M; Righino B; Filippetti F; Battaglia A; Petrillo M; Pirolli D; Scambia G; De Rosa MC; Gallo D
    Sci Rep; 2018 Oct; 8(1):16047. PubMed ID: 30375481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitotic cascade of NIMA family kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases.
    Belham C; Roig J; Caldwell JA; Aoyama Y; Kemp BE; Comb M; Avruch J
    J Biol Chem; 2003 Sep; 278(37):34897-909. PubMed ID: 12840024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA.
    Kandli M; Feige E; Chen A; Kilfin G; Motro B
    Genomics; 2000 Sep; 68(2):187-96. PubMed ID: 10964517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations.
    Saxena S; Abdullah M; Sriram D; Guruprasad L
    J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase.
    Belham C; Comb MJ; Avruch J
    Curr Biol; 2001 Aug; 11(15):1155-67. PubMed ID: 11516946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis.
    Yin MJ; Shao L; Voehringer D; Smeal T; Jallal B
    J Biol Chem; 2003 Dec; 278(52):52454-60. PubMed ID: 14563848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo.
    Lizcano JM; Deak M; Morrice N; Kieloch A; Hastie CJ; Dong L; Schutkowski M; Reimer U; Alessi DR
    J Biol Chem; 2002 Aug; 277(31):27839-49. PubMed ID: 12023960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells.
    Jeon YJ; Lee KY; Cho YY; Pugliese A; Kim HG; Jeong CH; Bode AM; Dong Z
    J Biol Chem; 2010 Sep; 285(36):28126-33. PubMed ID: 20595392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation.
    Minoguchi S; Minoguchi M; Yoshimura A
    Biochem Biophys Res Commun; 2003 Feb; 301(4):899-906. PubMed ID: 12589797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase inhibitor profile for human nek1, nek6, and nek7 and analysis of the structural basis for inhibitor specificity.
    Moraes EC; Meirelles GV; Honorato RV; de Souza Tde A; de Souza EE; Murakami MT; de Oliveira PS; Kobarg J
    Molecules; 2015 Jan; 20(1):1176-91. PubMed ID: 25591119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9.
    Richards MW; O'Regan L; Mas-Droux C; Blot JM; Cheung J; Hoelder S; Fry AM; Bayliss R
    Mol Cell; 2009 Nov; 36(4):560-70. PubMed ID: 19941817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation.
    Lee MY; Kim HJ; Kim MA; Jee HJ; Kim AJ; Bae YS; Park JI; Chung JH; Yun J
    Cell Cycle; 2008 Sep; 7(17):2705-9. PubMed ID: 18728393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human NIMA-related kinase 6 is one of the Fe65 WW domain binding proteins.
    Lee EJ; Hyun SH; Chun J; Kang SS
    Biochem Biophys Res Commun; 2007 Jul; 358(3):783-8. PubMed ID: 17512906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Nek6 is a monomeric mostly globular kinase with an unfolded short N-terminal domain.
    Meirelles GV; Silva JC; Mendonça Yde A; Ramos CH; Torriani IL; Kobarg J
    BMC Struct Biol; 2011 Feb; 11():12. PubMed ID: 21320329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to design potent and selective DYRK1B inhibitors? Molecular modeling study.
    Szamborska-Gbur A; Rutkowska E; Dreas A; Frid M; Vilenchik M; Milik M; Brzózka K; Król M
    J Mol Model; 2019 Jan; 25(2):41. PubMed ID: 30673861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase.
    Hashimoto Y; Akita H; Hibino M; Kohri K; Nakanishi M
    Biochem Biophys Res Commun; 2002 May; 293(2):753-8. PubMed ID: 12054534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIMA-related kinase-6 (NEK6) as an executable target in cancer.
    Panchal NK; Mohanty S; Prince SE
    Clin Transl Oncol; 2023 Jan; 25(1):66-77. PubMed ID: 36074296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.